# Subcutaneous Immunotherapy in Patients Sensitized to Phleum Pratense

> **NCT01489033** · PHASE1 · COMPLETED · sponsor: **Roxall Medicina España S.A** · enrollment: 42 (actual)

## Conditions studied

- Allergic Rhinoconjunctivitis

## Interventions

- **BIOLOGICAL:** Subcutaneous immunotherapy with Phleum pratense pollen extract

## Key facts

- **NCT ID:** NCT01489033
- **Lead sponsor:** Roxall Medicina España S.A
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-04
- **Final completion:** 2010-05
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2017-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01489033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01489033, "Subcutaneous Immunotherapy in Patients Sensitized to Phleum Pratense". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01489033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*